Personalizing the Treatment of Women with Ductal Carcinoma In Situ (DCIS) Using the DCIS Score: A Qualitative Study on Score Use
CONCLUSIONS: ROs had concerns about the overtreatment of women with DCIS, but lacked the tools to reliably predict which women could safely avoid radiation. By providing oncologists and women with personalized tumor information, the DCIS score was an important component of treatment decision making.PMID:38392067 | PMC:PMC10887948 | DOI:10.3390/curroncol31020073
Source: Current Oncology - Category: Cancer & Oncology Authors: Mary Ann O'Brien Lawrence Paszat Tutsirai Makuwaza Cindy Fong Eileen Rakovitch Source Type: research
More News: Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Carcinoma in Situ | DCIS (Ductal Carcinoma in Situ) | Ductal Carcinoma | Genetics | Legislation | Study | Women